Event

Charlotte Hogben

MSc Cardio-respiratory Nursing
Royal Brompton and Harefield NHS Foundation Trust;Royal Brompton Hospital

Felix J. Chua

PhD
Royal Brompton and Harefield NHS Foundation Trust;Royal Brompton Hospital

Peter M. George

MBBS, BSc(Hons), PhD, MRCP(UK)
Royal Brompton and Harefield NHS Foundation Trust;Royal Brompton Hospital

Philip L. Molyneaux

MRCP(UK), MBBS, BS(Hons)
Imperial College;Imperial College London;Royal Brompton and Harefield NHS Foundation Trust;Royal Brompton Hospital

Toby M. Maher

MD, MSc, PhD, FRCP
Imperial College;Imperial College London;Imperial College, London;National Institute for Health Research Respiratory Biomedical Research Unit, Royal Brompton and Hare;Royal Brompton and Harefield NHS

Vasileios Kouranos

MD, MSci, PhD
Royal Brompton Hospital

Elisabetta A. Renzoni

PhD
Royal Brompton Hospital;Royal Brompton Hospital/Imperial College

Athol Wells

M.D.
Interstitial Lung Disease Unit, Royal Brompton Hospital;Royal Brompton and Harefield NHS Foundation Trust, and National Heart and Lung Institute, Imperial C;Royal Brompton Hospital

Maria Kokosi

MD
Royal Brompton Hospital

Indication for and Impact of Switching from Pirfenidone to Nintedanib in Idiopathic Pulmonary Fibrosis